Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease
- PMID: 34489678
- PMCID: PMC8417045
- DOI: 10.3389/fnagi.2021.707950
Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease
Abstract
Down syndrome (DS) is the primary genetic cause of intellectual disability (ID), which is due to the triplication of human chromosome 21 (HSA21). In addition to ID, HSA21 trisomy results in a number of neurological and physiological pathologies in individuals with DS, including progressive cognitive dysfunction and learning and memory deficits which worsen with age. Further exacerbating neurological dysfunction associated with DS is the concomitant basal forebrain cholinergic neuron (BFCN) degeneration and onset of Alzheimer's disease (AD) pathology in early mid-life. Recent single population RNA sequencing (RNA-seq) analysis in the Ts65Dn mouse model of DS, specifically the medial septal cholinergic neurons of the basal forebrain (BF), revealed the mitochondrial oxidative phosphorylation pathway was significantly impacted, with a large subset of genes within this pathway being downregulated. We further queried oxidative phosphorylation pathway dysregulation in Ts65Dn mice by examining genes and encoded proteins within brain regions comprising the basocortical system at the start of BFCN degeneration (6 months of age). In select Ts65Dn mice we demonstrate significant deficits in gene and/or encoded protein levels of Complex I-V of the mitochondrial oxidative phosphorylation pathway in the BF. In the frontal cortex (Fr Ctx) these complexes had concomitant alterations in select gene expression but not of the proteins queried from Complex I-V, suggesting that defects at this time point in the BF are more severe and occur prior to cortical dysfunction within the basocortical circuit. We propose dysregulation within mitochondrial oxidative phosphorylation complexes is an early marker of cognitive decline onset and specifically linked to BFCN degeneration that may propagate pathology throughout cortical memory and executive function circuits in DS and AD.
Keywords: Alzheimer’s disease; Down syndrome; basal forebrain; oxidative phosphorylation; selective vulnerability.
Copyright © 2021 Alldred, Lee, Stutzmann and Ginsberg.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- ABI (2004). “Guide to performing relative quantitation of gene expression using real-time quantitative PCR,” in Applied Biosystems Product Guide, 1–60.
-
- Alldred M. J., Chao H. M., Lee S. H., Beilin J., Powers B. E., Petkova E., et al. . (2018). CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of down syndrome and Alzheimer’s disease following maternal choline supplementation. Hippocampus 28, 251–268. 10.1002/hipo.22832 - DOI - PMC - PubMed
-
- Alldred M. J., Chao H. M., Lee S. H., Beilin J., Powers B. E., Petkova E., et al. . (2019). Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of down syndrome and Alzheimer’s disease. FASEB J. 33, 9871–9884. 10.1096/fj.201802669RR - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
